Patent ID: 11884736
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The antibody or antigen-binding fragment thereof of claim 2, wherein:
(a) the HCDR1 comprises an amino acid sequence of SEQ ID NO: 4;
(b) the HCDR2 comprises an amino acid sequence of SEQ ID NO: 6;
(c) the HCDR3 comprises an amino acid sequence of SEQ ID NO: 8;
(d) the LCDR1 comprises an amino acid sequence of SEQ ID NO: 12;
(e) the LCDR2 comprises an amino acid sequence of SEQ ID NO: 14; and
(f) the LCDR3 comprises an amino acid sequence of SEQ ID NO: 16; or
(a) the HCDR1 comprises an amino acid sequence of SEQ ID NO: 24;
(b) the HCDR2 comprises an amino acid sequence of SEQ ID NO: 26;
(c) the HCDR3 comprises an amino acid sequence of SEQ ID NO: 28;
(d) the LCDR1 comprises an amino acid sequence of SEQ ID NO: 32;
(e) the LCDR2 comprises an amino acid sequence of SEQ ID NO: 14; and
(f) the LCDR3 comprises an amino acid sequence of SEQ ID NO: 34; or
(a) the HCDR1 comprises an amino acid sequence of SEQ ID NO: 42;
(b) the HCDR2 comprises an amino acid sequence of SEQ ID NO: 44;
(c) the HCDR3 comprises an amino acid sequence of SEQ ID NO: 46;
(d) the LCDR1 comprises an amino acid sequence of SEQ ID NO: 50;
(e) the LCDR2 comprises an amino acid sequence of SEQ ID NO: 52; and
(f) the LCDR3 comprises an amino acid sequence of SEQ ID NO: 54.